About Aro Biotherapeutics
Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Undisclosed
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
arobiotx.com
Domain Registered Date
Aug 11, 2017
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $41,500,000 · Series-B+
fundraisingfox.com
- Milestone
X account created (@AroBioTx)
126 followers
- Milestone
Website domain registered
arobiotx.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Aro Biotherapeutics.
Funding History
Series-B+
· Nov 28, 2023
$41,500,000 fundraisingfox.com
Founders & Leadership
Karyn O'Neil
Co-founder and Chief Scientific Officer
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026